ArticleScience translational medicine2022

Targeting an alternate Wilms' tumor antigen 1 peptide bypasses immunoproteasome dependency.

Miranda C Lahman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.